Adnan M. M. Mjalli,Bapu Gaddam,Dharma Rao Polisetti,Matthew J. Kostura,Mustafa Guzel
申请号：
US16113327
公开号：
US20180360839A1
申请日:
2018.08.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to chemical compounds of Formula (I) are as herein defined, pharmaceutical compositions, and methods of use in the treatment of conditions or disorders mediated by TNF-α or by PDE4, including but not limited to ulcerative colitis and Crohn's disease.
